NCT07535710 2026-04-17
Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
Shanghai Jiao Tong University School of Medicine
Phase 1/2 Not yet recruiting
Clinical Trials
175 trialsNCT07472322 2026-04-14
ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1
University of Wisconsin, Madison
Phase 1/2 Not yet recruiting
NCT07407582 2026-04-13
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
University of Arizona
Phase 1/2 Not yet recruiting
NCT07468136 2026-04-13
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Mayo Clinic
Phase 1/2 Not yet recruiting
NCT07522411 2026-04-13
Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma
Tongji Hospital
Phase 1/2 Not yet recruiting
NCT07510841 2026-04-06
JY016 Injection in Patients With Advanced Solid Tumors Expressing EGFR
Biotech Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
NCT07225985 2026-04-03
Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer Center
Phase 1/2 Not yet recruiting
NCT07509008 2026-04-03
Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum
M.D. Anderson Cancer Center
Phase 1/2 Not yet recruiting
NCT07506668 2026-04-02
RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas
Affiliated Hospital of Nantong University
Phase 1/2 Not yet recruiting
NCT07502768 2026-03-31
EpiRev-NKT
Fudan University
Phase 1/2 Not yet recruiting
NCT07247201 2026-03-30
AlloNK1
Singapore General Hospital
Phase 1/2 Not yet recruiting
NCT07494448 2026-03-27
JAZMINE
MedSIR
Phase 1/2 Not yet recruiting
NCT05108870 2026-03-25
TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers
University of Chicago
Phase 1/2 Not yet recruiting
NCT07486648 2026-03-24
Precision
Shanxi Province Cancer Hospital
Phase 1/2 Not yet recruiting
NCT07392957 2026-03-23
Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma
Washington University School of Medicine
Phase 1/2 Not yet recruiting
NCT07479979 2026-03-23
Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma
Hoosier Cancer Research Network
Phase 1/2 Not yet recruiting
NCT07320963 2026-03-20
Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.
Sun Yat-sen University
Phase 1/2 Not yet recruiting
NCT07477444 2026-03-20
HER-OIC
Universitaire Ziekenhuizen KU Leuven
Phase 1/2 Not yet recruiting
NCT07486726 2026-03-20
Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia
Shanghai Jiao Tong University School of Medicine
Phase 1/2 Not yet recruiting
NCT07048314 2026-03-19
Stem Cells for Erectile Dysfunction Post RALP
The Methodist Hospital Research Institute
Phase 1/2 Not yet recruiting
NCT07477418 2026-03-17
PRISM-TAMP
University of Vermont
Phase 1/2 Not yet recruiting
NCT07387354 2026-03-16
MDS
Thomas Jefferson University
Phase 1/2 Not yet recruiting
NCT07411599 2026-03-12
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")
M.D. Anderson Cancer Center
Phase 1/2 Not yet recruiting
NCT07372885 2026-03-11
GRACE
University of Manchester
Phase 1/2 Not yet recruiting
NCT04520139 2026-03-10
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
University of California, Irvine
Phase 1/2 Not yet recruiting
NCT06639607 2026-03-10
PRiME II
Washington University School of Medicine
Phase 1/2 Not yet recruiting
NCT07460986 2026-03-10
BEXAR
MedSIR
Phase 1/2 Not yet recruiting
NCT07456852 2026-03-09
Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy
Mayo Clinic
Phase 1/2 Not yet recruiting
NCT07453225 2026-03-05
Empirical Radioactive Iodine Therapy in DTC
Assiut University
Phase 1/2 Not yet recruiting
NCT07053020 2026-03-04
A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)
M.D. Anderson Cancer Center
Phase 1/2 Not yet recruiting
NCT07354100 2026-03-04
(BLOOM)
University of Chicago
Phase 1/2 Not yet recruiting
NCT07446725 2026-03-03
A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors
Suzhou Genhouse Bio Co., Ltd.
Phase 1/2 Not yet recruiting
NCT07277322 2026-03-02
Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases
Icahn School of Medicine at Mount Sinai
Phase 1/2 Not yet recruiting
NCT07441889 2026-03-02
HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
University of Virginia
Phase 1/2 Not yet recruiting
NCT07435584 2026-02-27
EVER-RECODE
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1/2 Not yet recruiting
NCT07283679 2026-02-24
Phase I/II Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer Center
Phase 1/2 Not yet recruiting
NCT07428148 2026-02-23
Lattice-Based Radiotherapy and Chemoimmunotherapy for Oropharyngeal Squamous Cell Carcinoma
NYU Langone Health
Phase 1/2 Not yet recruiting
NCT07389239 2026-02-20
A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.
University of Chicago
Phase 1/2 Not yet recruiting
NCT07408583 2026-02-19
Prenatal Transplantation for Fetuses With Fanconi Anemia
Stanford University
Phase 1/2 Not yet recruiting
NCT07420959 2026-02-19
ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia
Mayo Clinic
Phase 1/2 Not yet recruiting
NCT07217990 2026-02-17
NoCUT-BC
Ohio State University Comprehensive Cancer Center
Phase 1/2 Not yet recruiting
NCT07412197 2026-02-17
PREVENT-Lynch
Radboud University Medical Center
Phase 1/2 Not yet recruiting
NCT07414940 2026-02-17
ACT-RESoLUTE
University College, London
Phase 1/2 Not yet recruiting
NCT07398638 2026-02-10
Lisatoclax Plus R-CHOP or Pola-R-CHP in Untreated DLBCL: A Phase Ib/II Study
Sun Yat-sen University
Phase 1/2 Not yet recruiting
NCT07389278 2026-02-05
Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)
University of California, San Francisco
Phase 1/2 Not yet recruiting
NCT06638125 2026-02-02
3-Dimensional Virtual Reality Modelling With Intravascular Indocyanine Green Fluorescence Mapping for Targeted Pulmonary Segmental Resection Trial
St. Joseph's Healthcare Hamilton
Phase 1/2 Not yet recruiting
NCT07377526 2026-01-30
Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer
M.D. Anderson Cancer Center
Phase 1/2 Not yet recruiting
NCT07370506 2026-01-29
Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
Phase 1/2 Not yet recruiting
NCT07372807 2026-01-28
RIPERT-MG
Xinqiao Hospital of Chongqing
Phase 1/2 Not yet recruiting
NCT07370064 2026-01-27
AML CAR-T
Xuzhou Medical University
Phase 1/2 Not yet recruiting